ROIV
NASDAQ · Biotechnology
Roivant Sciences Ltd
$28.56
+0.28 (+0.99%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
+181.6% upside
Low Target
$62.72
Average Target
$80.43
High Target
$106.86
Current Price
$28.56
Current
$28.56
$28.56
Target
$80.43
$80.43
$62.72
$80.43 avg
$106.86
Scenario Analysis
Bear Case
$62.72
119.6%
Low target
Base Case
$80.43
+181.6%
Avg target
Bull Case
$106.86
+274.2%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$30.33
-5.8% from high
52-Week Low
$10.58
+169.9% from low
50-Day SMA
$23.00
+24.2% vs SMA
200-Day SMA
$16.34
+74.8% vs SMA
RSI (14)
76.4
Overbought
Target vs 52W High
$80.43
+165.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +27.8% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 28 | 96% | $143.40 | +41.5% |